1.The following patent, filed as a PCT (04/20/2015) in USA, Canada and Europe was allowed by the USPTO (15/305,550; filing date 10/20/2016; Inventor: Ronald Turner) in August 2018 and is expected to be granted by December 2018
This relates to the technology utilised to produce the point of care tests being commercialised as an aid to detection and management (Antibiotic Susceptibility) of Urinary Tract Infection (UTI)
2. Test & Treat has entered a lease agreement for premises on Lanwades Business Park, Kentford, Newmarket UK to be used to manufacture diagnostic reagents.
3. Test&Treat is pleased to announce that the PCT submission “Rapid Determination of Bacterial Susceptibility to an Antibiotic at the Point of Care” (Application No. 15/305550) was granted by the United States Patent and Trademark Office (USPTO) on November 20th 2018”